CT
CERE

ClearAlpha Technologies’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

ClearAlpha Technologies’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-149,438
Closed -$6.11M – 325
2024
Q2 		$6.11M Buy
149,438
+62,320
+72% +$2.55M 2.02% 10
2024
Q1 		$3.68M Buy
87,118
+51,732
+146% +$2.19M 1.55% 13
2023
Q4 		$1.5M Buy
+35,386
New +$1.5M 0.56% 40